STOCK TITAN

Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) is set to announce its Q2 financial results for the period ending June 30, 2022, before the market opens on August 4, 2022. A conference call will follow at 8:00 AM ET for discussions on the financial results.

Participants interested in joining the call can register here.

Loading...
Loading translation...
Argus Session date unavailable
+3.65% session move Open Argus
Details

News Market Reaction – HBIO

The recorded move for HBIO in the trading session of this news was +3.65%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on August 4, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 

Participants who want to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. 

Participants who want to join the audio-only webcast should go to our events and presentations on the investor website here. 

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website. 

About Harvard Bioscience 

Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe and China, we sell through a combination of direct and distribution channels to customers around the world. 

For more information, please visit our website at www.harvardbioscience.com. 

Investor Contact 
Michael Rossi 
Chief Financial Officer 
(508) 893-8999 
mrossi@harvardbioscience.com 



FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Harvard Bioscience announce its Q2 earnings results?

Harvard Bioscience will announce its Q2 earnings results on August 4, 2022, before the market opens.

What time is the Harvard Bioscience conference call?

The conference call to discuss the financial results will be held at 8:00 AM ET on August 4, 2022.

How can I participate in the Harvard Bioscience earnings call?

Participants must register to join the earnings call, which can be done through a link provided in the press release.

Where can I find the earnings release and presentation?

The earnings release and related slide presentation will be available on the Investor Relations section of Harvard Bioscience's website.

Keep reading